Biggest News Aggregation in the World
๐Ÿ“ฐ Care Phase News

Care Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Care Phase. Real-time updates on events, politics, business and more.

BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer's Dementia -April 10, 2024 at 07:01 am EDT

Company plans to initiate trial following recent meeting with FDA No FDA-approved therapies for acute treatment of AAD are currently available NEW HAVEN, Conn., April 10, 2024 -- BioXcel...
Erik Kopp Vincent Oneill David Schull Brennan Doyle Scott Stachowiak Product Development

EQS-News: Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19 Seite 1

19.08.2021 - EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with ... Seite 1
Advita Lifescience Gmb National Institutes Of Health Pharma Research Nrx Pharmaceuticals Inc Relief Reports Positive Safety Report

Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAM

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study19.08.2021 / 07:00  Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Critical Care Study in Patients with Life-Threatening COVID-19Geneva, Switzerland...
United Kingdom Michael Miller Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research

EQS-News: Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with Life-Threatening COVID-19 19.08.2021 / 07:00 ย  Relief Reports...
United Kingdom Michael Miller Jack Weinstein Advita Lifescience Gmb National Institutes Of Health Pharma Research

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science